Ru Feng, MD

Department of Hematology, Nanfang Hospital, The Southern Medical University

Poster(s):

• 1408 - Optimizing Time-Limited Therapy in Unfit CLL/SLL Patients: Orelabrutinib, Bendamustine, and Obinutuzumab Combination (OBG) Regimen